Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GammaMed is a specialized medical technology company recognized for its pioneering work in brachytherapy, a form of internal radiation therapy used to treat various cancers. The company developed the GammaMedplus series of high-dose-rate (HDR) and pulsed-dose-rate (PDR) afterloaders, which allow for the precise delivery of radioactive sources directly into or near a tumor. Founded in Germany, GammaMed established itself as a leader in the brachytherapy market before being acquired by Varian Medical Systems in 2001. Following the acquisition, its technology was integrated into Varian's oncology platform, and the GammaMed brand continues to be a standard in radiation oncology departments worldwide. The company's solutions include both hardware afterloaders and integrated treatment planning software designed to optimize patient outcomes in oncology. Today, as part of the Siemens Healthineers portfolio, GammaMed products remain essential tools for clinicians treating gynecological, prostate, and breast malignancies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GammaMed.